GleamWall
中文EN

EVH Evolent Health, Inc.

Services-Management Services · NYSE · SEC CIK 1628908 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.1%
TTM net income YoY-296.1%
TTM EPS YoY-187.3%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR—

Margins

Gross margin15.0%
Operating margin-18.5%
Net margin-21.7%
FCF margin—
EBITDA margin-13.9%

Returns

ROE-83.6%
ROA-23.0%
ROIC (approx.)-23.0%
Asset turnover1.06x

Leverage & solvency

Liabilities / assets81.0%
Debt / equity2.60x
Current ratio1.26x
Interest coverage-6.23x

Cash quality & payout

Operating cash flow / net income-0.13x
Accruals ratio-25.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q42025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$725.37M$652.52M$496.25M$468.72M$479.53M$444.33M$483.65M$646.54M
Cost of revenue$636.95M$571.68M$412.47M$371.47M$379.76M$343.94M$381.18M$570.83M
Gross profit$88.42M$80.84M$83.77M$97.25M$99.77M$100.39M$102.47M$75.71M
SG&A expense$73.12M$68.83M$72.82M$72.66M$77.59M$75.21M$78.41M$47.70M
Operating income-$6.19M-$9.56M-$10.60M-$408.23M$886,000-$1.17M-$1.62M-$18.60M
Interest expense$17.00M$16.86M$16.87M$19.01M$16.48M$11.60M$10.38M$6.72M
Pretax income-$22.45M-$25.65M-$25.72M-$430.81M-$19.96M-$20.72M-$63.15M-$23.92M
Income tax$1.12M$2.71M$910,000-$1.68M$906,000-$825,000$1.47M-$1.12M
Net income-$23.57M-$28.36M-$26.63M-$429.13M-$20.86M-$19.90M-$64.62M-$22.80M
EBITDA$15.30M$12.01M$10.96M-$363.19M$24.50M$21.97M$22.44M$10.70M
EPS (basic)-0.21-0.25-0.24-3.84-0.24-0.44-0.63-0.27
EPS (diluted)-0.21-0.25-0.24-3.84-0.24-0.44-0.63-0.27
Weighted avg. shares (diluted)113.07M112.54M111.91M—114.07M115.88M115.31M—
Balance sheet
Cash & equivalents$148.25M$115.70M$142.03M$151.86M$116.65M$151.00M$246.55M$178.50M
Receivables$442.77M$449.12M$314.16M$309.86M$386.56M$358.76M$430.50M$414.68M
Current assets$617.12M$610.51M$502.01M$506.37M$570.09M$562.26M$727.93M$607.12M
PP&E, net$82.51M$81.92M$81.18M$80.78M$80.09M$77.27M$74.44M$73.15M
Goodwill$694.42M$694.43M$694.43M$694.48M$1.08B$1.14B$1.14B$1.14B
Intangibles$539.17M$554.43M$569.68M$584.94M$623.69M$651.17M$667.88M$680.16M
Total assets$1.96B$1.97B$1.88B$1.90B$2.45B$2.46B$2.65B$2.54B
Current liabilities$489.94M$492.83M$381.24M$385.26M$429.93M$557.52M$739.10M$715.50M
Short-term debt———$0$5.12M$172.12M$171.79M$171.47M
Long-term debt$969.48M$966.47M$973.49M$970.54M$1.05B$648.46M$647.53M$490.52M
Total debt$969.48M$966.47M$973.49M$970.54M$1.06B$820.57M$819.33M$661.99M
Total liabilities$1.59B$1.59B$1.48B$1.48B$1.61B$1.34B$1.52B$1.35B
Shareholders' equity$372.85M$383.22M$396.39M$415.19M$842.23M$896.00M$935.52M$1.00B
Net debt$821.23M$850.76M$831.46M$818.68M$943.29M$669.58M$572.78M$483.49M
Cash flow statement
Operating cash flow$26.38M-$9.31M-$984,000$48.80M$15.81M-$30.33M$4.57M-$26.23M
Investing cash flow-$7.06M-$6.70M-$6.41M$82.15M-$8.76M-$60.53M-$13.09M-$19.93M
Financing cash flow-$4.55M-$10.99M-$3.97M-$93.04M-$41.81M-$8.93M$107.85M$96.94M
Depreciation & amortization$21.49M$21.57M$21.55M$45.04M$23.61M$23.14M$24.06M$29.30M
Stock-based compensation$14.80M$15.20M$10.65M$2.40M$14.68M$11.58M$11.08M-$6.12M
Share buybacks———$0———$0

Free plan shows the latest 8 periods; Pro shows all 51 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.